Printer Friendly
The Free Library
5,671,888 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Zacks Buy List Highlights: Meridian Bioscience, Inc., Infosys Technologies Limited, SMART Modular Technologies, Inc. and Ceradyne, Inc.


CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Everyday on Zacks.com, four stocks are selected based on how well they match the criteria for the four main schools of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today are Meridian Bioscience, Inc. (Nasdaq: VIVO (Video In Video Out) Refers to a display adapter with analog video capture and analog video out (NTSC out) capabilities. See display adapter. ), Infosys Technologies Limited (Nasdaq: INFY INFY Infosys Technologies Ltd (stock symbol) ), SMART Modular Technologies, Inc. (Nasdaq: SMOD SMOD Super Mod (gaming, Half Life 2 modification)
SMOD Serial Port Mode (Intel 8051 Microcontroller)
SMOD Staff Member On Duty
SMOD Secondary Means of De-Energization
), and Ceradyne, Inc. (Nasdaq: CRDN CRDN Certified Restoration Drycleaning Network ).

Stocks ranked #1 (Strong Buy) by Zacks have produced an average annual return of +32.4% since inception in 1988. During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8% while the S&P 500 tumbled 37.6%. To see the full Zacks #1 Rank (Strong Buy) List, or the rank for any other stock, visit: http://at.zacks.com/?id=88

Here is a synopsis of today's Zacks Rank Buy Stocks:

Aggressive Growth - Meridian Bioscience, Inc. (Nasdaq: VIVO)

Meridian Bioscience, Inc. has exceeded analyst expectations for five consecutive quarters. Year-over-year growth has been consistently in the double digits Double Digits was a pricing game on the American television game show, The Price Is Right. Played from April 20, 1973 through May 18, 1973's show, it was played for a car and used small prizes.  over the past few years. Both analysts covering the stock have raised their estimates for next year. Over the past 60 days, next year's numbers have increased 7.9% to 82 cents per share Cents per share

The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned.
.

Growth & Income - Infosys Technologies Limited (Nasdaq: INFY)

Infosys Technologies Limited topped analysts' earnings estimates in 10 out of the past 13 quarters by an average margin of 8.0%. Earnings per share are forecasted to grow 28% over the next 3-5 years. The company increased revenues, expanded gross margins and grew profits for the past six years. INFY has a current dividend yield of 1.0% and its return on equity crushes that of the industry averageCo36% compared to 13%.

Momentum - SMART Modular Technologies, Inc. (Nasdaq: SMOD)

On Sep 28, SMART Modular Technologies, Inc. reported earnings per share of 19 cents, a 5.6% surprise over the consensus estimate of 18 cents. SMOD set a new historic high the day after the earnings report, gapping higher and reaching $11.10 on very heavy volume before closing down on the day. What to make of such a failed breakout? SMOD clearly got carried away in the aftermath of the earnings report. Yet the heavy volume and extreme price movement indicates that investors want to believe in this company and its stock.

Value - Ceradyne, Inc. (Nasdaq: CRDN)

Ceradyne, Inc., a Zacks #1 Rank stock, exceeded analysts' earnings expectations in 14 out of the past 15 quarters by an average margin of 21.2%. The company reported record profits and revenues for the second quarter in early August, as well as for the first six months of 2006. As a result, CRDN upped its 2006 revenue and earnings per share guidance. The company has a price-to-book ratio of 3.4, compared to 5.3 for the market. CRDN's PEG ratio PEG Ratio

See: Prospective earnings growth ratio


PEG ratio

See price-earnings/growth ratio (PEG ratio).
 is 0.63.

Truly taking advantage of the Zacks Rank requires the understanding of how it works. The free special report, "Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions," provides an insightful background about this wealth-building tool. Download your free copy of the report now to prosper in the years to come by visiting http://at.zacks.com/?id=93.

About the Zacks Rank

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." A $10,000 investment in the Zacks Rank list made in 1988 would now be worth $1.80 million - equivalent to a 32.4% annualized annualized

Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared.
 return! During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8%, while the S&P 500 tumbled 37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have underperformed the S&P 500 by 145.9% annually (+4.7% vs. +11.6%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.

Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform Outperform

An analyst recommendation meaning a stock is expected to do slightly better than the market return.

Notes:
Exact definitions vary by brokerage, but in general this rating is better than neutral and worse than buy or strong buy.
 the market. Subscribe to Verb 1. subscribe to - receive or obtain regularly; "We take the Times every day"
subscribe, take

buy, purchase - obtain by purchase; acquire by means of a financial transaction; "The family purchased a new car"; "The conglomerate acquired a new company";
 this free newsletter today by visiting http://at.zacks.com/?id=90.

About Zacks

Zacks.com is a property of Zacks Investment Research Zacks Investment Research

A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms.
, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros http://at.zacks.com/?id=91

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

(*)The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment Reinvestment

Using dividends, interest and capital gains earned in an investment or mutual fund to purchase additional shares or units, rather than receiving the distributions in cash.

1. In terms of stocks, it is the reinvestment of dividends to purchase additional shares.
 of all dividends, no transaction costs Transaction Costs

Costs incurred when buying or selling securities. These include brokers' commissions and spreads (the difference between the price the dealer paid for a security and the price they can sell it).
, and represents the gross returns before management fees.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation solicitation

In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual
 to buy or sell any security.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 4, 2006
Words:941
Previous Article:Zacks Sell List Highlights: Journal Register, Timken, Dow Jones and 99 Cents Only.
Next Article:Xechem Receives $473,181 SBIR Grant From NIH-NHLBI to Conduct Toxicity Studies of 5-HMF Compound.



Related Articles
Zacks Buy List Highlights: Ceradyne, KOS Pharmaceuticals, Bed Bath & Beyond, and United Microelectronics.
Zacks Buy List Highlights: Ceradyne, Mandalay Resort Group, American Eagle Outfitters, and Qualcomm.
Zacks Buy List Highlights: Ceradyne, Estee Lauder, Adaptec, and FedEx Corporation.
Zacks Buy List Highlights: Ceradyne, NCR Corporation, Nordstrom, and Semtech Corporation.
Zacks Buy List Highlights: Ceradyne, KB Home, Altera Corporation, and QUALCOMM.
Zacks.com Announces That Donald Rowe Highlights the Following Stocks: Boyd Gaming, Meridian Bioscience, Inc., Monster Worldwide, Nextel Partners and...
Zacks.com Announces That Donald Rowe Highlights the Following Stocks: Meridian Bioscience, Inc., Park-Ohio Holdings Corp. and Virage Logic Corp.
Zacks Buy List Highlights: Infosys Technologies Limited, Precision Castparts Corp., American Oil & Gas, Inc., and Knight Capital Group, Inc.
Zacks Buy List Highlights: SMART Modular Technologies, The Goldman Sachs Group, Terex and The First Marblehead Corporation.
Zacks Buy List Highlights: SiRF Technology Holdings, Inc., Rockwell Collins, Inc., Sonic Innovations, Inc. and Ceradyne, Inc.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles